A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-FInding Study of Elismetrep (K-304) in the Treatment of Acute Migraine

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06848075

Title field or adapter rule

{'original_value': 'A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-FInding Study of Elismetrep (K-304) in the Treatment of Acute Migraine', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:33.132979+00:00

Published At

2026-08-27T00:00:00+00:00

Record Updated At

2026-10-20

Results Posted At

2026-08-27

Source Retrieved At

2026-10-31T22:18:36.041217+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Migraine"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-20", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06848075"

protocolSection.identificationModule.officialTitle

"A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-FInding Study of Elismetrep (K-304) in the Treatment of Acute Migraine"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

{"date": "2026-08-27", "type": "ACTUAL"}

Study condition terms

• Migraine (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Elismetrep (K-304) Dose Level 1'], 'description': 'Administered orally', 'name': 'Elismetrep (K-304) 2 mg', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Elismetrep (K-304) Dose Level 2'], 'description': 'Administered orally', 'name': 'Elismetrep (K-304) 5 mg', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Elismetrep (K-304) Dose Level 3'], 'description': 'Administered orally', 'name': 'Elismetrep (K-304) 10 mg', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Elismetrep (K-304) Dose Level 4'], 'description': 'Administered orally', 'name': 'Elismetrep (K-304) 20 mg', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Placebo'], 'description': 'Administered orally', 'name': 'Placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Elismetrep (K-304) 2 mg (protocolSection.armsInterventionsModule.interventions[].name)
• Elismetrep (K-304) 5 mg (protocolSection.armsInterventionsModule.interventions[].name)
• Elismetrep (K-304) 10 mg (protocolSection.armsInterventionsModule.interventions[].name)
• Elismetrep (K-304) 20 mg (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.